Roberto  de Mezerville net worth and biography

Roberto de Mezerville Biography and Net Worth

Mr. Mezerville has held positions of increasing responsibility at our company since 2009 in the areas of quality management, research and development, innovation and regulatory and clinical affairs and has been our Vice President of Quality and R&D since June 2015. From 2006 to 2009, Mr. Mezerville served in various engineering and quality manager positions with Allergan Medical Costa Rica. He has a Bachelor’s Degree in Business Administration from Universidad Interamericana de Costa Rica and a Bachelor’s degree in Industrial Environmental Health and Safety Engineering from Instituto Tecnologico de Costa Rica.

What is Roberto de Mezerville's net worth?

The estimated net worth of Roberto de Mezerville is at least $6.35 million as of May 20th, 2021. Mr. de Mezerville owns 122,800 shares of Establishment Labs stock worth more than $6,353,672 as of April 16th. This net worth evaluation does not reflect any other investments that Mr. de Mezerville may own. Learn More about Roberto de Mezerville's net worth.

How old is Roberto de Mezerville?

Mr. de Mezerville is currently 43 years old. There are 4 older executives and no younger executives at Establishment Labs. The oldest executive at Establishment Labs is Mr. S. Ross Mansbach, General Counsel & Chief Compliance Officer, who is 57 years old. Learn More on Roberto de Mezerville's age.

How do I contact Roberto de Mezerville?

The corporate mailing address for Mr. de Mezerville and other Establishment Labs executives is Building B15 and 25 Coyol Free Zone, Alajuela G2, . Establishment Labs can also be reached via phone at (062) 434-2400 and via email at [email protected]. Learn More on Roberto de Mezerville's contact information.

Has Roberto de Mezerville been buying or selling shares of Establishment Labs?

Roberto de Mezerville has not been actively trading shares of Establishment Labs during the last ninety days. Most recently, Mezerville Roberto De sold 9,490 shares of the business's stock in a transaction on Thursday, May 20th. The shares were sold at an average price of $74.40, for a transaction totalling $706,056.00. Following the completion of the sale, the chief technology officer now directly owns 122,800 shares of the company's stock, valued at $9,136,320. Learn More on Roberto de Mezerville's trading history.

Who are Establishment Labs' active insiders?

Establishment Labs' insider roster includes Juan Chacon-Quiros (Founder), Dennis Condon (Director), Roberto de Mezerville (CTO), Renee Gaeta (CFO), Lisa Gersh (Director), Nicholas Lewin (Director), and Edward Schutter (Director). Learn More on Establishment Labs' active insiders.

Are insiders buying or selling shares of Establishment Labs?

During the last twelve months, Establishment Labs insiders bought shares 3 times. They purchased a total of 9,250 shares worth more than $214,052.50. The most recent insider tranaction occured on December, 14th when Director Nicholas Sheridan Lewin bought 2,000 shares worth more than $54,080.00. Insiders at Establishment Labs own 12.6% of the company. Learn More about insider trades at Establishment Labs.

Information on this page was last updated on 12/14/2023.

Roberto de Mezerville Insider Trading History at Establishment Labs

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2021Sell9,490$74.40$706,056.00122,800View SEC Filing Icon  
5/18/2021Sell44$74.00$3,256.00122,800View SEC Filing Icon  
12/17/2020Sell8,000$33.14$265,120.00140,844View SEC Filing Icon  
12/15/2020Sell2,000$33.00$66,000.00140,844View SEC Filing Icon  
12/7/2020Sell10,000$30.14$301,400.00142,844View SEC Filing Icon  
5/13/2020Buy10$17.13$171.30152,844View SEC Filing Icon  
See Full Table

Roberto de Mezerville Buying and Selling Activity at Establishment Labs

This chart shows Mezerville Roberto De's buying and selling at Establishment Labs by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Establishment Labs Company Overview

Establishment Labs logo
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Read More

Today's Range

Now: $51.74
Low: $50.14
High: $52.61

50 Day Range

MA: $46.09
Low: $35.80
High: $55.38

2 Week Range

Now: $51.74
Low: $16.96
High: $77.55


327,378 shs

Average Volume

439,108 shs

Market Capitalization

$1.41 billion

P/E Ratio


Dividend Yield